542 related articles for article (PubMed ID: 18364097)
1. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
2. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
Hershkovitz R; de Swiet M; Kingdom J
Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening.
Filippi E; Staughton J; Peregrine E; Jones P; Huttly W; Peebles DM; Pandya P; David AL
Ultrasound Obstet Gynecol; 2011 May; 37(5):520-7. PubMed ID: 21520313
[TBL] [Abstract][Full Text] [Related]
5. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin.
Alkazaleh F; Chaddha V; Viero S; Malik A; Anastasiades C; Sroka H; Chitayat D; Toi A; Windrim RC; Kingdom JC
Am J Obstet Gynecol; 2006 Mar; 194(3):821-7. PubMed ID: 16522419
[TBL] [Abstract][Full Text] [Related]
7. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
Konchak PS; Bernstein IM; Capeless EL
Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
[TBL] [Abstract][Full Text] [Related]
9. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
10. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images.
Toal M; Keating S; Machin G; Dodd J; Adamson SL; Windrim RC; Kingdom JC
Am J Obstet Gynecol; 2008 Mar; 198(3):330.e1-7. PubMed ID: 18313456
[TBL] [Abstract][Full Text] [Related]
11. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
Elsandabesee D; Srinivas M; Kodakkattil S
J Obstet Gynaecol; 2006 Feb; 26(2):115-7. PubMed ID: 16483965
[TBL] [Abstract][Full Text] [Related]
14. Screening for placental insufficiency in high-risk pregnancies: is earlier better?
Costa SL; Proctor L; Dodd JM; Toal M; Okun N; Johnson JA; Windrim R; Kingdom JC
Placenta; 2008 Dec; 29(12):1034-40. PubMed ID: 18930542
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin.
Barkehall-Thomas A; Wilson C; Baker L; ni Bhuinneain M; Wallace EM
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):743-7. PubMed ID: 16026398
[TBL] [Abstract][Full Text] [Related]
16. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
17. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
19. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
Coleman MA; McCowan LM; North RA
Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
[TBL] [Abstract][Full Text] [Related]
20. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies.
Schwarze A; Nelles I; Krapp M; Friedrich M; Schmidt W; Diedrich K; Axt-Fliedner R
Arch Gynecol Obstet; 2005 Jan; 271(1):46-52. PubMed ID: 15185101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
